Accessibility: Skip TopNav
Figure 1
Atacicept 72-week Data From the Phase 2b ORIGIN Trial Are Consistent With a Profile of True Disease Modification
Format
PNG
Source
Vera Therapeutics
Downloads
Original
Large
Medium
Small